Nasdaq · ADR
argenx (ARGX)
$869.33 −$4.38 (−0.50%)
- Day’s range
- $864.11–$884.18
- Volume
- 267,985
ARGX price history
ARGX closed at $869.33 on Oct. 26, 2026. Over the past year, its daily close ranged from $663.93 on March 20, 2026 to $1,058.90 on Aug. 27, 2026.
Data table: ARGX daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $869.33 |
| Oct. 23, 2026 | $873.71 |
| Oct. 22, 2026 | $875.76 |
| Oct. 21, 2026 | $890.05 |
| Oct. 20, 2026 | $869.72 |
| Oct. 19, 2026 | $825.61 |
| Oct. 16, 2026 | $819.14 |
| Oct. 15, 2026 | $846.27 |
| Oct. 14, 2026 | $818.30 |
| Oct. 13, 2026 | $802.64 |
| Oct. 12, 2026 | $812.30 |
| Oct. 9, 2026 | $825.03 |
| Oct. 8, 2026 | $818.63 |
| Oct. 7, 2026 | $928.44 |
| Oct. 6, 2026 | $930.52 |
| Oct. 5, 2026 | $912.87 |
| Oct. 2, 2026 | $919.21 |
| Oct. 1, 2026 | $936.00 |
| Sept. 30, 2026 | $958.91 |
| Sept. 29, 2026 | $970.66 |
| Sept. 28, 2026 | $972.25 |
| Sept. 25, 2026 | $959.49 |
| Sept. 24, 2026 | $962.22 |
| Sept. 23, 2026 | $945.82 |
| Sept. 22, 2026 | $963.79 |
| Sept. 21, 2026 | $988.20 |
| Sept. 18, 2026 | $990.32 |
| Sept. 17, 2026 | $995.77 |
| Sept. 16, 2026 | $984.69 |
| Sept. 15, 2026 | $979.76 |
| Sept. 14, 2026 | $990.54 |
| Sept. 11, 2026 | $984.39 |
| Sept. 10, 2026 | $984.04 |
| Sept. 9, 2026 | $1,002.31 |
| Sept. 8, 2026 | $1,007.07 |
| Sept. 4, 2026 | $1,033.15 |
| Sept. 3, 2026 | $1,053.46 |
| Sept. 2, 2026 | $1,055.37 |
| Sept. 1, 2026 | $1,028.51 |
| Aug. 31, 2026 | $1,031.66 |
| Aug. 28, 2026 | $1,023.21 |
| Aug. 27, 2026 | $1,058.90 |
| Aug. 26, 2026 | $1,047.10 |
| Aug. 25, 2026 | $1,019.49 |
| Aug. 24, 2026 | $1,011.11 |
| Aug. 21, 2026 | $1,039.78 |
| Aug. 20, 2026 | $1,038.12 |
| Aug. 19, 2026 | $1,032.86 |
| Aug. 18, 2026 | $992.99 |
| Aug. 17, 2026 | $987.84 |
| Aug. 14, 2026 | $851.29 |
| Aug. 13, 2026 | $856.94 |
| Aug. 12, 2026 | $876.00 |
| Aug. 11, 2026 | $864.74 |
| Aug. 10, 2026 | $866.11 |
| Aug. 7, 2026 | $865.04 |
| Aug. 6, 2026 | $875.30 |
| Aug. 5, 2026 | $867.94 |
| Aug. 4, 2026 | $844.50 |
| Aug. 3, 2026 | $830.79 |
| July 31, 2026 | $853.82 |
| July 30, 2026 | $872.58 |
| July 29, 2026 | $882.56 |
| July 28, 2026 | $872.23 |
| July 27, 2026 | $888.82 |
| July 24, 2026 | $918.22 |
| July 23, 2026 | $924.60 |
| July 22, 2026 | $851.72 |
| July 21, 2026 | $874.74 |
| July 20, 2026 | $846.19 |
| July 17, 2026 | $860.55 |
| July 16, 2026 | $857.97 |
| July 15, 2026 | $862.93 |
| July 14, 2026 | $859.43 |
| July 13, 2026 | $876.25 |
| July 10, 2026 | $877.62 |
| July 9, 2026 | $909.49 |
| July 8, 2026 | $915.30 |
| July 7, 2026 | $919.94 |
| July 6, 2026 | $916.80 |
| July 2, 2026 | $939.68 |
| July 1, 2026 | $909.50 |
| June 30, 2026 | $927.77 |
| June 29, 2026 | $912.46 |
| June 26, 2026 | $887.18 |
| June 25, 2026 | $888.65 |
| June 24, 2026 | $852.50 |
| June 23, 2026 | $853.40 |
| June 22, 2026 | $903.75 |
| June 18, 2026 | $877.72 |
| June 17, 2026 | $892.26 |
| June 16, 2026 | $878.49 |
| June 15, 2026 | $884.20 |
| June 12, 2026 | $893.52 |
| June 11, 2026 | $898.94 |
| June 10, 2026 | $862.18 |
| June 9, 2026 | $884.00 |
| June 8, 2026 | $882.41 |
| June 5, 2026 | $891.32 |
| June 4, 2026 | $842.27 |
| June 3, 2026 | $813.14 |
| June 2, 2026 | $802.17 |
| June 1, 2026 | $836.09 |
| May 29, 2026 | $835.99 |
| May 28, 2026 | $838.49 |
| May 27, 2026 | $820.63 |
| May 26, 2026 | $808.43 |
| May 22, 2026 | $806.46 |
| May 21, 2026 | $816.22 |
| May 20, 2026 | $804.25 |
| May 19, 2026 | $797.77 |
| May 18, 2026 | $776.26 |
| May 15, 2026 | $799.32 |
| May 14, 2026 | $822.13 |
| May 13, 2026 | $802.70 |
| May 12, 2026 | $812.81 |
| May 11, 2026 | $813.28 |
| May 8, 2026 | $782.17 |
| May 7, 2026 | $787.31 |
| May 6, 2026 | $807.55 |
| May 5, 2026 | $794.70 |
| May 4, 2026 | $811.09 |
| May 1, 2026 | $783.50 |
| April 30, 2026 | $781.72 |
| April 29, 2026 | $776.02 |
| April 28, 2026 | $775.03 |
| April 27, 2026 | $783.74 |
| April 24, 2026 | $780.25 |
| April 23, 2026 | $787.95 |
| April 22, 2026 | $793.22 |
| April 21, 2026 | $805.38 |
| April 20, 2026 | $834.45 |
| April 17, 2026 | $849.04 |
| April 16, 2026 | $828.35 |
| April 15, 2026 | $840.87 |
| April 14, 2026 | $828.35 |
| April 13, 2026 | $809.27 |
| April 10, 2026 | $799.65 |
| April 9, 2026 | $800.50 |
| April 8, 2026 | $785.07 |
| April 7, 2026 | $765.43 |
| April 6, 2026 | $748.25 |
| April 2, 2026 | $746.42 |
| April 1, 2026 | $743.12 |
| March 31, 2026 | $730.25 |
| March 30, 2026 | $704.31 |
| March 27, 2026 | $691.40 |
| March 26, 2026 | $692.83 |
| March 25, 2026 | $697.05 |
| March 24, 2026 | $677.50 |
| March 23, 2026 | $681.85 |
| March 20, 2026 | $663.93 |
| March 19, 2026 | $684.50 |
| March 18, 2026 | $684.77 |
| March 17, 2026 | $706.03 |
| March 16, 2026 | $703.30 |
| March 13, 2026 | $700.45 |
| March 12, 2026 | $708.85 |
| March 11, 2026 | $728.09 |
| March 10, 2026 | $742.79 |
| March 9, 2026 | $740.40 |
| March 6, 2026 | $717.80 |
| March 5, 2026 | $728.11 |
| March 4, 2026 | $749.56 |
| March 3, 2026 | $748.72 |
| March 2, 2026 | $756.76 |
| Feb. 27, 2026 | $766.92 |
| Feb. 26, 2026 | $771.53 |
| Feb. 25, 2026 | $816.95 |
| Feb. 24, 2026 | $840.28 |
| Feb. 23, 2026 | $826.25 |
| Feb. 20, 2026 | $844.41 |
| Feb. 19, 2026 | $847.26 |
| Feb. 18, 2026 | $845.35 |
| Feb. 17, 2026 | $843.55 |
| Feb. 13, 2026 | $821.96 |
| Feb. 12, 2026 | $833.54 |
| Feb. 11, 2026 | $834.55 |
| Feb. 10, 2026 | $833.16 |
| Feb. 9, 2026 | $828.24 |
| Feb. 6, 2026 | $811.45 |
| Feb. 5, 2026 | $820.31 |
| Feb. 4, 2026 | $850.87 |
| Feb. 3, 2026 | $851.72 |
| Feb. 2, 2026 | $835.68 |
| Jan. 30, 2026 | $840.50 |
| Jan. 29, 2026 | $847.72 |
| Jan. 28, 2026 | $846.76 |
| Jan. 27, 2026 | $864.42 |
| Jan. 26, 2026 | $833.16 |
| Jan. 23, 2026 | $814.74 |
| Jan. 22, 2026 | $827.02 |
| Jan. 21, 2026 | $816.37 |
| Jan. 20, 2026 | $809.64 |
| Jan. 16, 2026 | $800.01 |
| Jan. 15, 2026 | $813.24 |
| Jan. 14, 2026 | $799.33 |
| Jan. 13, 2026 | $810.51 |
| Jan. 12, 2026 | $796.00 |
| Jan. 9, 2026 | $788.49 |
| Jan. 8, 2026 | $795.57 |
| Jan. 7, 2026 | $822.94 |
| Jan. 6, 2026 | $803.74 |
| Jan. 5, 2026 | $800.88 |
| Jan. 2, 2026 | $839.99 |
| Dec. 31, 2025 | $840.95 |
| Dec. 30, 2025 | $837.90 |
| Dec. 29, 2025 | $837.45 |
| Dec. 26, 2025 | $844.92 |
| Dec. 24, 2025 | $849.95 |
| Dec. 23, 2025 | $845.95 |
| Dec. 22, 2025 | $852.04 |
| Dec. 19, 2025 | $854.99 |
| Dec. 18, 2025 | $847.05 |
| Dec. 17, 2025 | $862.05 |
| Dec. 16, 2025 | $851.42 |
| Dec. 15, 2025 | $850.95 |
| Dec. 12, 2025 | $877.94 |
| Dec. 11, 2025 | $889.49 |
| Dec. 10, 2025 | $890.11 |
| Dec. 9, 2025 | $889.41 |
| Dec. 8, 2025 | $900.76 |
| Dec. 5, 2025 | $901.17 |
| Dec. 4, 2025 | $915.97 |
| Dec. 3, 2025 | $921.80 |
| Dec. 2, 2025 | $915.36 |
| Dec. 1, 2025 | $894.90 |
| Nov. 28, 2025 | $911.98 |
| Nov. 26, 2025 | $917.63 |
| Nov. 25, 2025 | $917.93 |
| Nov. 24, 2025 | $906.74 |
| Nov. 21, 2025 | $918.92 |
| Nov. 20, 2025 | $918.50 |
| Nov. 19, 2025 | $914.59 |
| Nov. 18, 2025 | $918.53 |
| Nov. 17, 2025 | $929.61 |
| Nov. 14, 2025 | $907.98 |
| Nov. 13, 2025 | $891.73 |
| Nov. 12, 2025 | $889.89 |
| Nov. 11, 2025 | $889.64 |
| Nov. 10, 2025 | $869.83 |
| Nov. 7, 2025 | $854.65 |
| Nov. 6, 2025 | $851.02 |
| Nov. 5, 2025 | $832.35 |
| Nov. 4, 2025 | $831.48 |
| Nov. 3, 2025 | $826.28 |
| Oct. 31, 2025 | $818.50 |
| Oct. 30, 2025 | $820.36 |
| Oct. 29, 2025 | $821.97 |
| Oct. 28, 2025 | $836.39 |
| Oct. 27, 2025 | $829.83 |
Key figures
- 52-week range
- $663.93–$1,058.90Low March 20, 2026; high Aug. 27, 2026
- Average daily volume
- 349,369Past 3 months
- Market value
- $54.67B
- Dividend yield
- —
- From 52-week high
- −17.90%
Price change
- 1 month
- −9.40%
- 3 months
- −5.32%
- Year to date
- +3.37%
- 1 year
- +6.36%
$1,000 a year ago
$1,000 put into ARGX at the close on Oct. 24, 2025 would be worth $1,064.
Price only, dividends not included.
What Wall Street says about ARGX
In the past 90 days, Wall Street firms published 23 rating or price-target actions on ARGX: 1 upgrade, 1 new rating, 2 reiterated ratings, 13 raised price targets and 6 lowered price targets.
| Action | Rating | |||
|---|---|---|---|---|
| Baird | Raises target | Neutral | $823 to $861 | |
| Evercore ISI Group | Raises target | Outperform | $1,078 to $1,090 | |
| Guggenheim | Cuts target | Buy | $1,185 to $1,120 | |
| Morgan Stanley | Raises target | Overweight | $1,140 to $1,190 | |
| Wells Fargo | Cuts target | Overweight | $1,356 to $1,336 | |
| RBC Capital | Cuts target | Outperform | $1,100 to $1,025 | |
| Wells Fargo | Raises target | Overweight | $1,355 to $1,356 | |
| Oppenheimer | Cuts target | Outperform | $1,100 to $1,038 | |
| Baird | Cuts target | Neutral | $932 to $823 | |
| Evercore ISI Group | Cuts target | Outperform | $1,175 to $1,078 | |
| Wedbush | Reiterates | Outperform | $1,150 | |
| Wedbush | Reiterates | Outperform | $1,150 | |
| Morgan Stanley | Raises target | Overweight | $1,230 to $1,250 | |
| UBS | Upgrade | Neutral to Buy | $960 to $1,400 | |
| Wells Fargo | Raises target | Overweight | $1,350 to $1,415 | |
| Citizens | Raises target | Market outperform | $932 to $1,200 | |
| HC Wainwright & Co. | Raises target | Buy | $940 to $1,202 | |
| Morgan Stanley | Raises target | Overweight | $1,200 to $1,230 | |
| RBC Capital | Raises target | Outperform | $1,025 to $1,100 | |
| Truist Securities | Raises target | Buy | $1,030 to $1,095 | |
| Wedbush | Raises target | Outperform | $1,050 to $1,150 | |
| Piper Sandler | Raises target | Overweight | $1,075 to $1,215 | |
| Guggenheim | Reinstates coverage | Buy | $1,185 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About argenx SE American Depositary Shares
Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized myasthenia gravis (gMG). In 2022, Argenx also received FDA approval for Vyvgart Hytrulo, a subcutaneous formulation of Vyvgart, offering a more convenient option compared with Vyvgart's intravenous administration. In 2024, the FDA approved Vyvgart Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy, a rare immune-mediated neuromuscular disorder of the peripheral nervous system. Argenx is focused on innovation and developing its pipeline for treatments such as primary immune thrombocytopenia, thyroid eye disease, and Sjogren's Disease.
- Employees
- 1,863
- Listed
- May 18, 2017
In WallStreetDigest editions
No WallStreetDigest article about ARGX is on the site yet.